• Kjell Skappel


    Kjell is the founding partner of Stavanger Venture AS, a privately held Value Adding angel to venture phase Investment Company. Stavanger Venture AS was established together with TD Veen AS in 2010. Kjell came from the role as Regional Director Europe North in Cisco Systems. Prior to this, Kjell had several leading positions in TANDBERG ASA that was acquired by Cisco Systems.

  • Silje Veen

    Chairman of the Board

    Silje has a degree in marketing from The Norwegian Buisness School, BI specializing in local business development. She founded the food concept Food Story and managed it for more than 10 years.

  • Øyvind Schanke

    Chief Investment Officer

    Øyvind holds an MBA from NHH (Norwegian School of Economics) He has over 25 years of investment experience. Øyvind was previously the CEO of Skagen Funds. Prior to that he spent almost 16 years at the Norwegian Sovereign Wealth fund, the last years as the CIO for asset management based in London.

  • Jane S.Tvedt

    Investment Director+47 97686469

    Proir to joining TD Veen, Jane was a Portfolio Manager in Skagen for more than 10 years. She has also worked in Equinor, the Norwegian Central Bank and Econ. Jane holds a MSc degree in Economics and Econometrics from the University of Oslo

  • Jens Erich Jenssen

    Equty Analyst & Investment Manager +47 95261158

    Before joining TD Veen, Jens Erich worked as an Investment Manager in Nysnø Climate Investments. Jens Erich holds a MSc degree in Engineering and has previously worked as an Investment Analyst, Corporate Advisor and Equity Research Analyst.

  • Marit Øverland

    Coordinator+47 9203 1461

  • Anja Moen Hareim

    Manager +47 91352065

    Anja is manager of TD Veen's social entrepreneurs. She's a trained chef and was head chef at Food Story for 4 years.

  • Tor Dagfinn Veen

    Founder and Owner

    Tor Dagfinn is a business economist with more than 40 years of experience from the investment sector.

  • Susanne Stuffers

    CEO / Partner P53+47 9119 4204

    Susanne holds an M.D degree from the Erasmus University Rotterdam and a Ph.D. degree in cancer biomedicine from the Norwegian Radiumhospital. She has experience from management consultancy in health care and life science at EY (2014 - 2015), from medical and commercial roles in the pharmaceutical industry (Novartis, 2011 - 2014), and from clinical practice as a resident in oncology (OUS Ullevål, 2010 - 2011). Susanne worked with Artic Securities as an equity analyst covering the healthcare sector (2015 - 2018) and is currently CEO/partner of P53 Invest AS, an investment company with sole focus on health care investment.